Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GEMZAR vs GILTERITINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GEMZAR vs GILTERITINIB: Safety Overview

Metric GEMZAR GILTERITINIB
Total FAERS Reports 133 3,672
Deaths Reported 38 1,014
Death Rate 28.6% 27.6%
Hospitalizations 63 1,407
Average Patient Age 63.3 yrs 60.8 yrs
% Female Patients N/A 48.5%
FDA Approval Date N/A Nov 28, 2018
Manufacturer N/A Astellas Pharma US, Inc.
Route N/A ORAL
Marketing Status N/A Prescription